Fund comparison · from official SEC filings

IBBQ vs IDNA: how much do they overlap?

Invesco Nasdaq Biotechnology ETF and iShares Genomics Immunology and Healthcare ETF
Holdings overlap
15%
of assets, by weight
Shared positions
29
of 259 / 62 holdings
IBBQ expense ratio
0.19%
net, per year
IDNA expense ratio
0.47%
net, per year
Shared holdings
Company
IBBQ
IDNA
V
VRTXVERTEX PHARMACEUTICALS INC
6.17%
2.96%
R
RVMDREVOLUTION MEDICINES INC
2.08%
5.70%
M
MRNAMODERNA INC
1.24%
5.22%
R
REGNREGENERON PHARMACEUTICALS
4.25%
3.10%
B
BNTXBIONTECH SE-ADR
0.73%
3.39%
E
EXELEXELIXIS INC
0.87%
3.16%
T
TWSTTWIST BIOSCIENCE CORP
0.27%
3.15%
I
INCYINCYTE CORP
1.28%
2.93%
I
IDYAIDEAYA BIOSCIENCES INC
0.17%
2.25%
I
IBRXIMMUNITYBIO INC
0.51%
2.17%
C
CAICARIS LIFE SCIENCES INC
0.31%
2.03%
C
CRSPCRISPR THERAPEUTICS AG
0.36%
1.50%
N
NVAXNOVAVAX INC
0.12%
1.09%
I
IOVAIOVANCE BIOTHERAPEUTICS INC
0.11%
1.03%
V
VIRVIR BIOTECHNOLOGY INC
0.10%
0.89%
A
ABCLABCELLERA BIOLOGICS INC
0.12%
0.88%
C
CRVSCORVUS PHARMACEUTICALS INC
0.07%
0.80%
J
JANXJANUX THERAPEUTICS INC
0.06%
0.71%
K
KURAKURA ONCOLOGY INC
0.06%
0.69%
C
CTMXCYTOMX THERAPEUTICS INC
0.04%
0.50%
R
RIGLRIGEL PHARMACEUTICALS INC
0.04%
0.47%
N
NTLAINTELLIA THERAPEUTICS INC
0.11%
0.47%
P
PACBPACIFIC BIOSCIENCES OF CALIF
0.03%
0.40%
D
DSGNDESIGN THERAPEUTICS INC
0.04%
0.39%
A
ALVOALVOTECH SA
0.07%
0.33%
Only in IBBQ
?
Invesco Private Prime Fund
11.88%
G
GILDGILEAD SCIENCES INC
6.18%
A
AMGNAMGEN INC
5.94%
?
Invesco Private Government Fund
4.58%
A
ALNYALNYLAM PHARMACEUTICALS INC
2.67%
B
BIIBBIOGEN INC
1.91%
I
ILMNILLUMINA INC
1.66%
U
UTHRUNITED THERAPEUTICS CORP
1.62%
R
RPRXROYALTY PHARMA PLC- CL A
1.59%
A
ARGXARGENX SE - ADR
1.58%
I
INSMINSMED INC
1.53%
R
ROIVROIVANT SCIENCES LTD
1.43%
V
VTRSVIATRIS INC
1.25%
G
GHGUARDANT HEALTH INC
1.13%
N
NBIXNEUROCRINE BIOSCIENCES INC
1.06%
J
JAZZJAZZ PHARMACEUTICALS PLC
0.97%
A
ASNDASCENDIS PHARMA A/S
0.92%
S
SMMTSUMMIT THERAPEUTICS INC
0.91%
B
BBIOBRIDGEBIO PHARMA INC
0.85%
M
MEDPMEDPACE HOLDINGS INC
0.84%
I
IONSIONIS PHARMACEUTICALS INC
0.84%
A
AXSMAXSOME THERAPEUTICS INC
0.80%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.76%
B
BMRNBIOMARIN PHARMACEUTICAL INC
0.73%
A
ARWRARROWHEAD PHARMACEUTICALS IN
0.73%
Only in IDNA
B
BISXXBCF INSTITUTIONAL-SL AGNCY
17.45%
I
IPSEFIPSEN
4.36%
B
BAYZFBAYER AG-REG
3.64%
T
TKPHFTAKEDA PHARMACEUTICAL CO LTD
3.51%
M
MRKMERCK & CO. INC.
3.45%
G
GLAXFGSK PLC
3.43%
R
RHHVFROCHE HOLDING AG
3.32%
S
SNYNFSANOFI
2.98%
G
GNMSFGENMAB A/S
2.63%
R
RCUSARCUS BIOSCIENCES INC
1.77%
O
OPHLFONO PHARMACEUTICAL CO LTD
1.55%
2
2595GENFLEET THERAPEUTICS SHAN-H
1.00%
N
NUVBNUVATION BIO INC
0.98%
6
6887SUNSHINE LAKE PHARMA CO LT-H
0.52%
O
OCGNOCUGEN INC
0.49%
1
174900ABCLON INC
0.47%
S
SGBCFSHANGHAI HENLIUS BIOTECH I-H
0.42%
I
INRLFVALNEVA SE
0.37%
D
DNAGINKGO BIOWORKS HOLDINGS INC
0.33%
V
VSTMVERASTEM INC
0.33%
2
2591GUANGZHOU INNOGEN PHARMACE-H
0.11%
?
EURO
0.03%
M
MREOMEREO BIOPHARMA GROUP PL-ADR
0.03%
?
GREAT BRITISH POUND
0.01%
?
SWISS FRANC
0.00%
Hold IBBQ and IDNA together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.